BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2005
View Archived Issues
Glatiramer acetate reduces relapses more than beta interferons in multiple sclerosis
Read More
AZD-0530 inhibits osteoclast-mediated bone resorption in healthy volunteers
Read More
Lithium shows promise as anabolic bone therapy
Read More
Therapeutic benefits of melatonin in hemodialysis patients
Read More
SGN-35 shows potency in CD30+ malignancies in vitro; clinical trials to start shortly
Read More
20(S)-Protopanaxatriol exerts antitumor effects in lung cancer cells
Read More
CT-3: a novel synthetic cannabinoid for pain / News in Context
Read More
Novel tri-action somatostatin-dopamine agonists studied for control of GH secretion
Read More
FR-193262: a novel prostacyclin mimetic with oral bioavailability and antiaggregative effect
Read More
JYL-1421 is a potent TRPV1 antagonist in vitro and in vivo
Read More
PKCzeta --a novel target for asthma therapy
Read More
CJ-730: a novel matriptase inhibitor with antimetastatic properties
Read More
Marc Pharmaceuticals to investigate betulinol derivative for prostate cancer
Read More
Velcura receives SBIR for development of drugs for bone disorders
Read More
SR Pharma advances acquisition of Atugen
Read More
United Biomedical awarded NIH contract for therapeutic AIDS vaccine
Read More
Xenomics and Spallanzani sign definitive agreement for SpaXen joint venture
Read More
Corixa stockholder approval of merger with GlaxoSmithKline
Read More
Allergan to evaluate Pharmacopeia compounds in models of ocular disease
Read More
SBIR grant supports development AV-101 for neuropathic pain
Read More
Xsira receives IND clearance for phase II study of adenosine for pain
Read More
MEND-CABG study of MC-1 completes enrollment
Read More
Hemosol selects IGIV as first therapeutic protein product for development
Read More
New agents for gastrointestinal disorders described in recent patent literature
Read More
New antibacterial transcription inhibitors emerge from French R&D
Read More
